TNFSF10 and colorectal carcinoma: Consequently, combination of IgBD-TRAIL, but not TRAIL and PDT, efficiently eradicated tumor grafts of CRC cells with chemotherapeutic MDR and TRAIL resistance (Figure 6C, Figure 7C).